Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic and Autologous Stem Cell Transplant”

141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 141 results

Testing effectiveness (Phase 2)Study completedNCT00116467
What this trial is testing

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Cell Genesys 55
Post-approval studies (Phase 4)Study completedNCT02747615
What this trial is testing

Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty

Who this might be right for
Revision Total Hip Arthroplasty (RTHA)
Ain Shams University 60
Not applicableStudy completedNCT05352789
What this trial is testing

Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.

Who this might be right for
Haematological MalignancyBone Marrow Transplant ComplicationsStem Cell Transplant Complications+4 more
Nottingham University Hospitals NHS Trust 66
Testing effectiveness (Phase 2)Study completedNCT00625755
What this trial is testing

A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Beth Israel Deaconess Medical Center 40
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Not applicableNot Yet RecruitingNCT06741813
What this trial is testing

Allo-HSCT vs ASCT in Adult T-LBL

Who this might be right for
T Lymphoblastic Lymphoma
Peking University People's Hospital 230
Testing effectiveness (Phase 2)Study completedNCT01045460
What this trial is testing

Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Not applicableStudy completedNCT00510315
What this trial is testing

Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant

Who this might be right for
LeukemiaHodgkin's LymphomaNon-Hodgkin's Lymphoma+1 more
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)UnknownNCT01883518
What this trial is testing

Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma

Who this might be right for
SarcomaNeoplasms, Connective and Soft Tissue
N.N. Petrov National Medical Research Center of Oncology 48
Testing effectiveness (Phase 2)Ended earlyNCT00121186
What this trial is testing

S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 1
Early research (Phase 1)Study completedNCT03340766
What this trial is testing

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Amgen 31
Testing effectiveness (Phase 2)WithdrawnNCT01326273
What this trial is testing

Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

Who this might be right for
CMV ReactivationAllogeneic Stem Cell TransplantationAutologous CMV Specific CD8+ T Cells
Imperial College London
Not applicableLooking for participantsNCT04263857
What this trial is testing

Register of Blood Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Technical University of Munich 5,000
Testing effectiveness (Phase 2)Study completedNCT01008462
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more
Fred Hutchinson Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT00075829
What this trial is testing

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 710
Early research (Phase 1)Looking for participantsNCT03081910
What this trial is testing

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

Who this might be right for
T-cell Acute Lymphoblastic LymphomaT-non-Hodgkin LymphomaT-cell Acute Lymphoblastic Leukemia
Baylor College of Medicine 54
Testing effectiveness (Phase 2)Study completedNCT01181271
What this trial is testing

Tandem Auto-Allo Transplant for Lymphoma

Who this might be right for
Diffuse, Large B-Cell, LymphomaLymphoma, Low-GradeT-Cell Lymphoma+4 more
Massachusetts General Hospital 42
Testing effectiveness (Phase 2)Study completedNCT00793572
What this trial is testing

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT01552707
What this trial is testing

Safety Study of Mesenchymal Stem Cells and Spinal Fusion

Who this might be right for
Lumbar Spondylolisthesis Involving L4-L5, and/orDegenerative Discopathy Involving L4-L5
Banc de Sang i Teixits 69
Early research (Phase 1)Ended earlyNCT00672152
What this trial is testing

A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation

Who this might be right for
Acute Myelogenous Leukemia (AML)Chronic Myelogenous Leukemia (CML)Acute Lymphoblastic Leukemia (ALL)+2 more
Michael Morse, MD 8
Load More Results